GM
GMVDF.US G Medical Innovations Holdings Ltd
- Market cap
- USD 3.35K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2022.
Is GMVDF.US undervalued?
Graham numberThe Graham number of G Medical Innovations Holdings Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
G Medical Innovations Holdings Ltd fundamental analysis
No fundamental analysis for G Medical Innovations Holdings Ltd yet.
G Medical Innovations Holdings Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About G Medical Innovations Holdings Ltd
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel. The company's products include Prizma, a multi-sensor device that measures vital signs and generate the health trend report; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data. It develops Wireless Vital Si…
Full company profileG Medical Innovations Holdings Ltd financial statements
G Medical Innovations Holdings Ltd annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | - | - | 84.0K | 2.37M | 3.89M | 4.90M | 4.96M | 4.42M |
| Gross Profit | -9.00K | -17.0K | -806K | -749K | -157K | 667K | 1.51M | 784K |
| Operating Income | -1.93M | -2.66M | -20.4M | -13.3M | -8.99M | -12.3M | -11.0M | -22.1M |
| EBITDA | -1.92M | -2.65M | -20.0M | -14.1M | -5.93M | -10.5M | -8.74M | -8.65M |
| Net Income | -1.99M | -3.02M | -20.8M | -13.1M | -10.9M | -12.5M | -14.8M | -24.6M |
| EPS | -1.48 | -2.25 | -16 | -6.65 | -4.93 | -60 | -45 | -34 |
| Balance Sheet | ||||||||
| Total Assets | 122K | 7.01M | 16.6M | 11.0M | 6.17M | 5.45M | 10.5M | 4.83M |
| Total Liabilities | 1.64M | 2.13M | 6.39M | 13.0M | 13.1M | 8.40M | 13.3M | 9.40M |
| Shareholders' Equity | -1.52M | 4.88M | 6.55M | -5.09M | -9.41M | -6.30M | -6.03M | -7.35M |
| Cash & Short-term Investments | 47.0K | 6.76M | 10.9M | 2.59M | 504K | 278K | 6.03M | 295K |
| Total Debt | 1.42M | 1.83M | 3.67M | 9.35M | 9.97M | 2.85M | 7.84M | 2.09M |
| Cash Flow | ||||||||
| Operating Cash Flow | -1.79M | -2.50M | -6.38M | -12.0M | -6.30M | -4.65M | -11.5M | -18.5M |
| Capital Expenditure | 48.0K | 89.0K | 1.15M | 1.83M | 429K | 507K | 550K | 2.12M |
| Free Cash Flow | -1.84M | -2.59M | -7.53M | -13.8M | -6.73M | -5.15M | -12.0M | -20.6M |
| Ratios | ||||||||
| ROE | - | -61.8% | -318.4% | - | - | - | - | - |
| ROA | -1,632.8% | -43.0% | -125.8% | -119.8% | -176.8% | -230.0% | -140.3% | -510.4% |
| Net Profit Margin | - | - | -24,823.1% | -554.4% | -280.7% | -255.8% | -297.5% | -557.2% |
| Debt to Equity | - | 0.38x | 0.56x | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
G Medical Innovations Holdings Ltd dividends
G Medical Innovations Holdings Ltd has not paid dividends in the last 8 fiscal years.
Last stock split: 1:35 on Nov 21, 2022.
Who owns G Medical Innovations Holdings Ltd
- Insiders 0.00%
- Institutions 0.01%
- Public & others 99.99%
- Shares outstanding 33.5M
- Free float 5.36M
G Medical Innovations Holdings Ltd company profile
- Company name
- G Medical Innovations Holdings Ltd
- Ticker
- GMVDF.US
- ISIN
- KYG394621414
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 84
- Fiscal year end
- December
- Address
- 5 Oppenheimer Street, Rehovot, Israel, 7670105
- Phone
- 972 8 958 4777
- Website
- gmedinnovations.com
About G Medical Innovations Holdings Ltd
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel. The company's products include Prizma, a multi-sensor device that measures vital signs and generate the health trend report; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, the company offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. Further, it provides various accessories for its healthcare products. G Medical Innovations Holdings Ltd was incorporated in 2014 and is based in Rehovot, Israel.
G Medical Innovations Holdings Ltd management
7- Dr. Yacov GevaCEO, President & Executive Director · born 1950
- Mr. Kobi Ben EfraimCFO & Controller · born 1955
- Mr. Tim LohmanVice President of Operations
- Mr. Benny TalVP of R&D Corporate and CTO Corporate · born 1959
- Mr. Oded ShaharSenior VP of Mergers & Acquisitions Corporate · born 1960
- Ms. Dror Nuriel-RothExecutive Vice President of US Operations · born 1975
- Mr. Brett TuckerCompany Secretary